AMYLOIDOSIS
Clinical trials for AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to tame rare Heart-Threatening disease
Disease control OngoingThis study tests a treatment plan using daratumumab plus chemotherapy for people newly diagnosed with AL amyloidosis, a rare condition where abnormal proteins damage organs, especially the heart. About 151 participants will receive the drug combination either right away or after …
Matched conditions: AMYLOIDOSIS
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 18, 2026 11:46 UTC
-
New chemo formula aims to boost transplant success in blood cancers
Disease control OngoingThis study tests a new, more stable version of the chemotherapy drug melphalan in people with multiple myeloma or AL amyloidosis who are getting a stem cell transplant. The goal is to find the best dose that reaches a target level in the body, while possibly causing fewer side ef…
Matched conditions: AMYLOIDOSIS
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
New scaffold material aims to ease nerve biopsy recovery
Knowledge-focused OngoingThis study tests whether a new scaffold material is safe to use when repairing a nerve after a biopsy. Normally, after a nerve biopsy, the nerve is not repaired, which can cause pain, swelling, and tenderness. The study involves 20 adults with various nerve conditions who need a …
Matched conditions: AMYLOIDOSIS
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:03 UTC